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Noes, The purpose of this study was to Investigate the
antladrenergic effects
of adenosine and carbachol on beta-
adrenoctlitor-stimulated human ventricular contractility In vivo
.
In addition, the andadrenergic effects of adenosine and carbachol
were compared In vitro .
SaAgmawl.
Adenosine Is reported to exhibit an antiadrener-
gk negative Inotrolik response in the bets-adrenergic-sdmulated
vent far myocardium In vitro
. The effect of adenosine is similar
to to s .tail A"engic effect of m-cholimiceptor stimulation in vitro
.
Methods. The inotropk response In vivo was assessed in seven
healthy volunteers by 11 I• echocardiography and simulta-
nem blood pressure nwalloring. It
was calculated as the increase
In
the rate-corrected velocity of circumferential fiber shortening
and in the systolic pressure/dimension ratio . All volunteers re-
ceived pretreatment with 450 mg of dipyridamole/day for
48 h. In
addition, the effects of adenosine and carbachol In the presence of
0
.03 pmolliller of Isoproterenol on cumulative concentration-
response curves of isolated, electrically driven human ventricular
muscle strips were compared In vitro (n = 13).
Results.
The
positive imilroplic response to continuous Infusion
of 20 uglkg per min of Isoproterenol (increase of rate-corrected
Adenosine produces negative chronotropic and dromotropic
effects in experimental animals and in humans
(1,2) . It is
used therapeutically to terminate supraventricular tachycar-
dia (3,4). Adenosine exerts a "direct" negative inotropic
effect in atrial tissue (5,6)
and attenuates the ventricular
inotropic response to beta-adrenergic stimulation in several
mammalian species (7-13) . This "indirect" negative inotro-
pic effect has also been demonstrated in human ventricular
myocardium in vitro (14) . It has been suggested that this
effect may protect the myocardium from sympathetic over-
stimulation .
The action of adenosine on myocardium is mediated by
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v
eloclto,f circumferential fiber shortening 110.2 ± 2.1% x
b
beatsin u
catshnin per insl and increase of systolic pressure/dimension
ratio 1 .09 ± 0,3 min Hg/mm) was significantly (p < 0.01) reduced
by 3.6k body weight of intravenous cabachol (4 .2 t 1 .2% x
beats/min per ms, 0 .21 :t 0.18 min Hg/mm) but not b 50W, kg
of intravenous adenosine (8 .2 t 3.1% x N/Weats/min per ms,
1 .35 ± 0.42 mm Hg/mm), although adenosine induced a signifi-
cant negative dromotropic effect. In vitro comparison of force of
contraction with cumulative concentration-response curves in the
presence of 0.03 innol/liter of isoproterenol demonstrated an EC 50
value (concentration producing'ov,&, maximal effect) for adenosine
466 times higher than that for carbachal (65 .3 vs . 0.14 jmmoNiter,
p < 0.001).
Conclusions
. In contrast to carbachol, adenosine does not
attenuate the catecholamine-induced increase in contractility in
the human ventricle in vivo . These differences between the A,-
ademisiae receptor- and m-cholinoceptor--inc-diated effects could
be due to fewer A,-adenosine receptors or a less efficient receptor-
effector coupling, or both .
(J Am Coll Cardiol 1994,23 :678-83)
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A,-adenosine receptors (13,15) . In atrial tissue, the cardiac
A 1-adenosine receptor is coupled by pertussis toxin-
sensitive guanine nucleotide binding proteins (G ig) to cardiac
potassium channels (16,17) . In ventricular tissue the A 1 -
receptor is coupled via G ia to adenylate cyclase (8,11,19),
thereby reducing cyclic adenosine monophosphate forma-
tion and the cyclic adenosine monophosphate-induced in-
crease in the slow calcium ion inward current (1,20,21) .
These effects of adenosine are shared by m-cholinoceptors,
which are also coupled to G 1 , (22-24). m-Cholinoceptor
stimulation exhibits an antiadrenergic effect on isolated
cardiac preparations (25,26) as well as the human ventricle in
vivo (27) .
However, the in vitro effects of m-cholinoceptor agonists
are more potent than those of A 1 -adenosine receptor ago-
nists or the parent compound (adenosine) itself (21,28) .
Thus, it is an open question whether an antiadrenergic
negative inotropic effect of adenosine on the human ventricle
exists in vivo . To address this issue, we assessed the effect
of adenosine on myocardial contractility echocardiographi-
cally during isoproterenol infusion in vivo. The effect of
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adenosine was compared with the carbachol-mediated anti-
adrenergic effect on contractility . To investigate potential
differences in receptor- ehictor coupling, concentration-
response curves for adenosine and carbachol were compared
in isolated human ventricular muscle strips in vitro,
Methods
Seven male volunteers with a mean age of 29 .7 ± 2 .6
years were studied. Because the lioavailabilky of adenosine
is hampered by its short plasma half-time, all volunteers
received pretreatment with dipyridamole (450 mg/day) for 2
days to block adenosine uptake (29). Pretreatment with
dipyridamole reduces the dose of adeno ; -ne needed to
induce an equieffective negative chronotropic and dromo-
tropic response to 25% (30) of that needed with adenosine
alone 0A. Continuous assessment of myocardial contrac-
tility was performed by two-dimensional--guided M-mode
echocardiography in the short-axis view using phased array
equipment with a 2.5-MHz transducer (Toshiba SSH 65 -A) .
All recordings were made by the same investigator and
evaluated in blinded manner by two experienced investiga-
tors. Systolic and diastolic blood pressures were measured
by an automated sphygmomanometer (Accutorr) . Heart rate
and the PR interval were obtained by simultaneous electro-
cardiographic (ECG) recordings . End-diastolic and end-
systolic diameters of the left ventricle and left ventricular
ejection time were measured as the mean of five cardiac
cycles according to standard guidelines (31) . The fractional
shortening was derived as 100 x End-diastolic diameter -
End-systolic diameter/End-diastolic diameter . As an addi-
tional variable of the contractile state, the rate-corrected
velocity of circumferential fiber shortening was calculated
as 10 x Fractional shortening x '00a rate/Left ventricu-
lar ejection time (32) . To control for the effects of potentially
different afterload conditions, the systolic pressure/dimension
ratio as an afterload-independent variable of inotropy was
calculated as Systolic blood pressure/End-systolic diameter
(33) .
Study protocol . After 15 min in the supine position, a
continuous intravenous infusion of isoproterenol was started
with 20 ng(kg body weight per min and was continued
throughout the whole investigation . Ten minutes after initi-
ation of isoproterenol infusion, a bolus injection of 50 µg/kg
of adenosine was administered intravenously . Fifteen min-
utes after return to baseline values, as assessed by ECG and
echocardiographic recordings, a slow continuous intra-
venous injection of carbachol (0.45 /Lg/kg per min) was
performed for 8 min for a total of 3.6 pg/kg of carbachol .
Echocardiographic and ECG recordings and blood pressure
measurements were taken at rest, 10 min after the start of
isoproterenol infusion, after injection of adenosine and after
application of the total dose of carbachol . Each subject
gave informed consent . The protocol was approved by the
Ethics Committee of the Ludwig-Maximilians-University of
Munich .
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Preparation of isolated ventricular muscle strips and mea-
surement of force of contraction . All experiments were per-
formed on isolated electrically stimulated human ventricular
papillary muscle strips . Tissue was obtained during mitral
valve replacement or heart transplantation . All seven pa-
tients gave written consent, before the operation . Papillary
muscle strips (n = 13 for every assay) of uniform size
(diameter <1 mm, length 3 to 6 mm) were dissected in an
aerated bath solution and were continuously gassed with
carbogen (9511 oxygen, 5% carbon dioxide) at 35°C and a pH
of 7 .4 . The preparations were attached to a bipolar platinum
stimulating electrode and suspended individually in 75-ml
glass tissue chambers to record isometric contractions . Each
muscle was stretched to a length at which the force of
contraction was maximal . The resting force (approximately
5 mN) was kept constant throughout the experiment. The
preparations were electrically paced at 1 Hz with rectangular
pulses of 5 ms . The voltage was -20% above threshold .
Concentration-dependent mechanical effects were obtained
by cumulative application of adenosine and carbachol under
maintenance of the isoproterenol concentration . Details of
the preparation and measurements have been published
elsewhere (15) .
Statistical analysis . For measurement of force of contrac-
tion, statistical analysis was estimated with the Student
9 test
for unpaired observations and analysis of variance (34) . For
all other data, analysis of variance was performed using
the ScheR range test for multiple comparisons (34) . All
calculated p values are two tailed . All p values < 0 .05 were
considered significant . All group data are given as mean
value ± SD .
Results
Pharmacologic stimulation in vivo . Baseline left ventricu-
lar function, heart rate and blood pressure were normal in all
subjects. During continuous intravenous infusion of isopro-
terenol (20 ng/kg per min), heart rate and myocardial con-
tractility (calculated as fractional shortening, rate-corrected
velocity of circumferential fiber shortening and systolic
pressure/dimension ratio) increased significantly . Left ven-
tricular ejection time decreased significantly (Tables I and.
2). Injection of adenosine (50 jig/kg) during continuous
isoproterenol infusion resulted in second- or third-degree
atrioventricular (AV) block in two volunteers and significant
prolongation of the Pk interval in the remaining five . Com-
pared with values with isoproterenol alone, blood pressure
and myocardial contractility did not change significantly
(Tables I and 2). In contrast, application of carbachol
(3.6 pg/kg) significantly decreased the inotropic and chrono-
tropic effects of isoproterenol. Thus, the positive inotropic
effect of isoproterenol (increase in rate-corrected velocity
of circumferential fiber shortening or increase in systolic
pressure/dimension ratio) was significantly reduced by car-
bachol but not by adenosine (Fig . 1) . End-diastolic diameter
and systolic blood pressure as variables for preload and
No
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Table 1
. Measurements at Rest, During Isoproterenol, During Isoproterenol and Adenosine and During Isoproterenol and Carbachol
carbachol (3.6 uglg
*p < 0 .01 (isoproterenol alone vs . rest or isoproterenol and carbachol vs
. isoproterenol and adenosine). tp < 0 .05 (isoproterenol alone vs. rest or iseproterenol
and carbachol vs. isopwrenol and adenosine)
. *Two volunteers were excluded with second- and third-degree atrioventricular blocks . §p < 0.01 (isoproterenol and
adenosine vs
. isoproterenol alone or isoproterenol and carbachol vs . isoproterenol alone) . lip < 0
.05 (isoproterenol and adenosine vs
. rest or isoproterenol
and catbachol vs . rest). Values presented are mean value ± SD
. DBP = diastolic blood pressure ; EDD = end-diastolic diameter ; ESD = end-systolic diameter :
SOP a systolic blood pressure : LVET = left ventricular ejection time .
afterload did not change significantly throughout the entire
investigation (Table 1) .
memrewnt of force of cmalraclilon in vitro. In ventric-
ular myocardium . increasing concentrations of adenosine
did not exhibit a direct negative inotropic effect . In contrast,
in the presence of isoproterenol an indirect negative ino-
tropic effect could be demonstrated (concentration produc-
ing half maximal effect
[EC501,
65.3 pnottliter) . At high
concentrations (>100 pmolAiter), carbacholl alone even in-
creased the force of contraction slightly . In the presence of
isoproterenol, carbachol also exerted a concentration-
dependent negative isotropic effect (EC .0.0.14 Amol/liter) .
The efficacy of adenosine was similar to that of carbachol,
but the potency, as judged from the
1
00 values to produce
an indirect negative inotropic response, was 466 times lower
than that of carbachol (Fig. 2) .
Discussion
In the present study the effect of exogenous adenosine on
catecholamine-enhanced ventricular contractility was exam-
Table 2. Fractional Shortening, Rate-Corrected Velocity of
Circumferential Fiber Shortening and Systolic Pressure/Dimension
Ratio as Indexes of Myocardial Contractility
'p < 0 .01 (isoproterenol alone vs, rest or isoproterenol and carbachol, vs
.
isoproterenol and adenosine). tp < 0.01 (isoproterenol and adenosine vs
. rest
^t isoproterenol and carbachol vs . rest)
. tp < 0.05 (isoproterenol and
adenosine vs
. isoproterenol alone or isoproterenol and carbachol vs
. isopro-
terenol alone)
. Values presented are mean value ± SD
. FS = fractional
shortening
; PID = systolic pressureldimension ratio
; V,r, = rate-corrected
velocity of circumferential fiber shortening
.
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fined in vivo . Adenosine did not attenuate the isoproterenol-
induced increase in ventricular contractility of the human
heart in vivo at a dosage that produced a significant nega-
tive dromotropic effect . In contrast, stimulation of m-
cholinoceptors by carbachol, as a receptor coupled to the
same second-messenger system, induced a significant indi-
rect negative inotropic effect on the ventricle in vivo . Com-
padson of concentration-response curves for the effects of
adenosine and carbachol on isolated human ventricular
muscle strips in vitro showed a similar efficacy but a 466-fold
lower potency for adenosine . It is likely that the lack of an
antiadrenergic inotropic effect of adenosine is based on
differences in receptor-effector coupling or a lower A,-
adenosine receptor density, or both . However, further in-
crease in the in vivo dosage of adenosine is limited by the
high degree of AV block and intolerable side effects, such as
chest discomfort, flushing and hyperventilation (3) .
Myocardial effects of adenosine ~- .ere first described by
Drury and Szent-Gy6rgyi (35) . They observed a negative
chronotvopic, dromotropic and inotropic effect in the guinea
pig heart in situ. In later studies, the inotropic effect of
adenosine was characterized separately in atrial and ventric-
ular myocardium. In atrial myocardium, adenosine elicits a
negative inotropic effect in several mammalian species
(5,6.36) . In ventricular tissue, adenosine alone failed to
reduce the force of contraction (7) . However, when the force
of contraction was stimulaied with isoproterenol (9,11),
adenosine exerted a negative inotropic response . This effect
has been described as an antiadrenergic or indirect negative
inotropic effect (7) . Similarly, m-cholinoceptor stimulation
induces negative chronotropic and dromotropic as well as
indirect negative inotropic effects in cardiac preparations
and the human heart in vivo (25-27).
The endogenous nucleoside adenosine is released from
myocardial and endothelial cells during hypoxemia (37),
ischemia (38) and excessive stimulation with catechola-
mines. It has been spec -Aated that adenosine plays a physi-
ologic role as a feedback inhibitor of myocardial contractility
by protecting the heart from excessive beta-adrenergic over-
stimulation .
Heart Rate
(beats/min)
PR Interval
(ms)
LVET
(ms)
SOP
(mm Hg)
DBP
(mm Hg)
EBB
(mm)
ESD
Rest
68.7 ± 11 .1 169 ± 17 291 ± 37 108 ± 11 55}9 48.6 ± 1 .9 31 .7 ± 3 .7
Isoproterenol
(20 nsft x min)
94.7 ± 12 .9* 157 ± 13 230 t ZY 113 ± 12 52±5
48.3 ± 1 .7 25 .4 ± 3 .0*
Isoproterenol and
adenosine (50 Pa)
83 .1 ± 12 .8 226 2: 601N 237 t 31i 121 ± 17 52 ± 5 48A ± 1 .7 25 .7 ± 3.111
lsopa*aamA and 75 .4 t 7 .71: 174 t 14t 252 t 15 103 ± 10 44 ± 5
49.7 ± 1 .5 28 .7 ± 3 .6
FS
(%)
V (% x
_:X&
Vbeatslminlms) (mm Hg/mm)
Rest 34.4±6 .2 10.1±3 3.4®•0.3
Isoproterenol
(20 ngft x min)
47.7±5 .1* 20.3±37' 4.5 •_ 0.6'
Isoproterenol and
adenosine (5a )
47.0±5 .3t 18.2±3.3t 4.8 ± 0.7t
lioprotcr"oi and
carbachol (3
.6 AN)
42.1 ± 6.7 K3 ± 30 3.6 ± opt
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Figure 1 . Increase in the rate-corrected velocity
of circumferential fiber shortening (AVc ,,:) (A) and
in the systolic pressure/dimension ratio (APID)
(B) from baseline values in seven healthy volun-
teers during isoproterenol, isoproterenol and
adenosine and isoproterenol and carbachol infu-
sion, respectively, p > 0 .05 was considered not
significant (ms .) . All group data are mean value
3D,
Wproterenol
(20 nWkg x min)
ISoproterenol and
Adanosine (50 µg/kg)
Isoproterenol and
Carbachol (3 .6 pig/kg)
The well known electrophysiologic properties of aden-
osine have led to its use as a therapeutic and diagnostic agent
in patients with supraventricular tachycardia (3,4). How-
ever, data on the effects of adenosine on ventricular contrac-
tility are sparse. In contrast, the in vivo properties of
adenosine as an "indirect" negative inotropic agent in the
ventricle have been investigated in several animal species
(7-13) . In isolated myocardial preparations from several
animal species as well as in experimental animals in situ,
attenuation of beta-adrenoceptor-stimulated contractility by
high concentrations of adenosine has been demonstrated
(7-13) . In humans, only in vitro data exist, demonstrating an
antiadrenergic negative inotropic response comparable to
the effect in animal myocardium . This raises the question
whether the in vitro (in human tissue) and in vivo (in several
animal species) evidence for an antiadrenergic negative iso-
tropic effect in the ventricle is inducible in humans in vivo .
Pharmaccologic stimulation in vivo . To ensure sufficient
bioavailability of the rapidly degradated adenosine (39),
pretreatment with the nucleoside uptake inhibitor dipyri-
damole was performed (40) . After pretreatment with dipyri-
damole, a dosage of 50 µg/kg of adenosine was shown to be
equieffective, in terms of prolongation of the PR interval (2),
to adenosine alone in higher therapeutic concentrations,
such as 100 to 200 pglg (3,4) . After application of aden-
osine, all volunteers in the present study exhibited signifi-
cant prolongation of AV conduction time . Two volunteers
developed a second- and third-degree AV block, respec-
tively. This documents the marked negative dromotropic
hopotemnol
RO ng/kg x ml
Isoprolerenol and
Adenosine (50 Kg/kg)
isoproterenol and
Carbachol (3 .6 pig/kg)
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effect of adenosine in ae present study. It must be kept in
mind that stimulation with isoproterenol alone causes an
increase in endogenous adenosine in the heart (41) . Thus,
even after an increase in endogenous adenosine by cate-
cholamine stimulation, administration of exogenous aden-
osine causes a significant negative dromotropic effect . How-
ever, no significant change in the isoproterenol-stimulated
ventricular contractility could be demonstrated in vivo . This
was in contrast to a significant antiadrenergic negative
inotropic effect of m-cholinoceptor stimulation with carba-
chol in the present study and in an independent earlier study
(27) . The antiadrenergic effects of carbachol and adenosine
may in part be attenuated by reflex sympathetic activation,
leading to positive chronotropic, drofliotropic and inotropic
stimulation as well as vasoconstriction . Carbachol in the
present study was a more potent stimulator of reflex sympa-
thetic activation than was adenosine in terms of an insigioif-
icant hypotensive vasodilating effect . Nevertheless, carba-
chol induced a significant antiadrenergic effect on ventricular
inotropy. Therefore, the lack of an indirect negative inotrop-
ic effect of adenosine cannot be explained by complete
masking due to reflex sympathetic activation .
In agreement with two previous studies performed in
anesthesized dogs (42,43), an adenosine-catecholamine an-
tagonism as a negative feedback mechanism preventing
excessive inotropic catecholamine stimulation seems to be
absent in the intact human ventricle in vivo . A potential
antiadrenergic effect of endogenous adenosine in pathophys-
iologic conditions was not investigated in the present study
.
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Concentration (MM0111)
During hypoxia or ischemia, interstitial myocardial aden-
osine concentrations may increase two-fold to sevenfold
(44) . Whether this extreme local myocardial accumulation of
endogenous adenosine may exert a local antiadrenergic
effect is unknown .
Measurement of force of contraction in vitro. Differences
in receptor-effector coupling of m-cholinoceptors and A,-
adenosine receptors may explain the different antiadrenergic
inotropic effects. In radioligand binding experiments (28) it
has been shown that in human myocardial ventricular tissue,
the density of m-cholinoceptors is significantly higher than
that of A,-adenosine receptors . This finding correlates with
the present study, revealing a significant difference in po-
tency between these compounds for their indirect negative
inotropic effect by comparing concentration-response curves
for adenosine and carbachol in isolated human ventricular
muscle strips . Compared with nonfailing myocardium, fail-
ing myocardium, which was investigated in our in vitro
experiments, exhibits an unchanged coupling, density, inhi-
JACC Vol . 23, No . 3
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Figure 2. Original tracings illustrating the
force of contraction of isolated electrically
driven human ventricular papillary muscle
strips alone and in the presence of 0 .03 pmoli
liter of isoproterenoi after application of 1,000
Mmol/liter of adenosine (A) and 10 umolhiter
of carbachol (B) . Cumulative concentration-
response curves for the effects of adenosine
and carbachol alone and in the presence of
0.03 jAmoilliter of isoproterenol (n = 13) (C) .
The ordinate represents the force of contrac-
tion in percent of the value before application
of adenosine or carbachol . The abscissa rep-
resents the concentration of adenosine and
carbachol .
bition of adenylate cyclase and antiadrenergic effect (18,28) .
Therefore, the in vitro results provide a reliable explanation
for the different in vivo effects of carbachol and adenosine .
These differences in potency are likely to explain why, in
contrast to carbachol, exogenous adenosine in physiologi-
cally tolerable and therapeutically effective doses does not
induce an antiadrener2w negative inotropic effect in vivo .
The administration of higher doses of adenosine is not
feasible because of severe negative chronotropic and dromo-
tropic effects (e.g. . cardiac arrest) and severe side effects
(e.g., chest discomfort) . Therefore, it cannot be excluded
that a toxic dose of exogenous adenosine may induce an
indirect negative inotropic effect .
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